DDW 2023 showcased some of the latest research and innovations in celiac disease. These included promising early results from four investigational medications currently being tested for the treatment of celiac disease, as well as CDF research conducted in partnership with Takeda and Adelphi Real World.
Continue ReadingThe ILLUMINATE Studies are phase 2 clinical research studies evaluating an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease.
Continue ReadingDigestive Disease Week, held this year in Chicago and virtually, is the world’s premier meeting for gastroenterology. The Celiac Disease Foundation is pleased to have presented original research – co-authored…
Continue ReadingThe Celiac Disease Foundation, a world leader in patient advocacy, and Takeda Development Center Americas, a global biopharmaceutical leader, today are proud to announce the Celiac Disease Foundation–Takeda Early Career Research Award.
Continue ReadingThe Celiac Disease Foundation is proud to continue our partnership with the Celiac Disease Center at Columbia University in presenting an annual free livestream international symposium, this year titled "Celiac Disease: On the Horizon". Registration open now.
Continue Reading